JP Patent

JP6267425B2 — 筋ジストロフィー治療のためのユートロフィン誘導に関するａｃｔｒｉｉｂタンパク質およびその改変体およびその使用

Assigned to アクセルロン ファーマ， インコーポレイテッド · Expires 2018-01-24 · 8y expired

What this patent protects

Patent listed against Phoslo.

Drugs covered by this patent

Patent Metadata

Patent number
JP6267425B2
Jurisdiction
JP
Classification
—
Expires
2018-01-24
Drug substance claim
No
Drug product claim
No
Assignee
アクセルロン ファーマ， インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.